Loading...
Erythropoiesis-stimulating agents and cardiovascular events in patients with myelodysplastic syndrome and multiple myeloma
INTRODUCTION: Erythropoiesis-stimulating agent (ESA) treatment has been associated with an increased risk of venous thromboembolism (VTE) in patients with solid tumors and with an increased risk of cardiovascular events in patients with chronic kidney disease. The ESA-related risk in patients with h...
Na minha lista:
| Udgivet i: | Clin Epidemiol |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6167129/ https://ncbi.nlm.nih.gov/pubmed/30310329 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CLEP.S172306 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|